Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight because the Security-as-a-Service model requires monitoring revenue growth and margin trajectory (income statement), cash conversion from subscriptions (cash flow), and the buildup of deferred revenue and leased asset base (balance sheet).

Composite Trajectory: Improving

The annual comparison (FY 2025 vs. FY 2024) shows improvement across all three statements. Revenue grew 40% to $145.9M while the operating loss narrowed 41% to -$48.5M and the net loss narrowed 39% to -$33.1M (10-K FY 2025, Consolidated Statements of Operations). Operating cash flow swung to a $18.7M inflow from a -$30.9M outflow (10-K FY 2025, Consolidated Statements of Cash Flows). Cash and marketable securities rose to $69.0M from $51.9M, deferred revenue (current + noncurrent) grew to $91.6M from $84.8M, and the company added a $30M term loan while remaining in covenant compliance (10-K FY 2025, Consolidated Balance Sheets; Liquidity and Capital Resources). The only material counter-trend is gross margin compression across every revenue stream, but operating leverage and cash generation improved decisively.

2. Red Flags

• Gross margin compression across all revenue streams: Product margin improved from -66% to -12% but remains negative; Subscription margin fell from 57% to 56%; Service margin fell from 78% to 71%; License fee margin fell from 93% to 89% (10-K FY 2025, MD&A Results of Operations).
• Recurring inventory write-offs: $2.9M in FY 2025 and $2.6M in FY 2024 for obsolete Edge and prior-generation Express components (10-K FY 2025, Note 8).
• Recurring restructuring charges: $2.7M in FY 2025 (January 2025 RIF) and $0.9M in FY 2024 (May 2024 RIF) (10-K FY 2025, Note 22).
• Large legal settlement accrual with insurance offset: $15.0M accrual in accrued expenses and $14.0M estimated insurance recovery in prepaid assets (10-K FY 2025, Note 11 and Note 9); net $1.0M loss recorded in G&A (10-K FY 2025, Note 19).
• Material non-cash gains masking operating loss: $15.4M total other income in FY 2025 driven by fair-value gains on earn-out liability ($12.4M), contingently issuable shares ($2.6M), and public warrants ($0.4M) (10-K FY 2025, Consolidated Statements of Operations).
• Customer concentration: Customer B represented 15.3% of FY 2025 revenue and 15.1% of year-end accounts receivable (10-K FY 2025, Note 2).
• Supplier concentration: All systems manufactured by Columbia Tech; new Plexus agreement signed November 2025 but onboarding risks noted (10-K FY 2025, MD&A Supply Chain Strategy; Note 2).
• Material weaknesses in revenue recognition: Auditor identified material weaknesses related to revenue recognition for products, subscription, service, and license fees (10-K FY 2025, Critical Audit Matters).
• Debt covenants with near-term triggers: Minimum ARR covenant of $106M (current ARR $120.5M), minimum liquidity of 50% of borrowings, and EBITDA covenant effective June 30, 2027 (10-K FY 2025, Liquidity and Capital Resources; Note 12).
• Ongoing government investigations: SEC subpoena (February 2024) and FTC order (December 2024) with potential for further penalties (10-K FY 2025, Note 19).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Total revenue increased 40% year-over-year to $145.9M (10-K FY 2025, Consolidated Statements of Operations). Subscription revenue, the core recurring stream, grew 29% to $83.8M. Gross profit rose 27% to $75.3M, but overall gross margin declined to 51.6% from 57.2% due to margin compression in every segment. Operating expenses fell 13% to $123.8M, driven by a 25% reduction in sales and marketing and a 12% reduction in R&D. Loss from operations narrowed 41% to -$48.5M and net loss narrowed 39% to -$33.1M. Adjusted EBITDA (non-GAAP) improved to $11.1M from -$21.0M (10-K FY 2025, MD&A Non-GAAP Financial Measures). ARR grew 21% to $120.5M and RPO grew ~13% to $293.6M (10-K FY 2025, MD&A Key Metrics).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow swung to a $18.7M inflow in FY 2025 from a -$30.9M outflow in FY 2024 (10-K FY 2025, Consolidated Statements of Cash Flows). The improvement was driven by a lower net loss, higher non-cash adjustments (depreciation/amortization $24.3M vs $17.4M, stock-based compensation $21.1M vs $24.8M), and favorable working capital changes including a $9.1M inventory reduction and a $6.9M increase in deferred revenue. Investing cash flow was -$41.8M vs -$1.4M, primarily due to $31.4M of property/equipment purchases (leased units) and net marketable securities purchases. Financing cash flow was $35.4M vs $1.8M, reflecting $26.3M net proceeds from the new term loan and $9.1M from stock option exercises. Ending cash and marketable securities totaled $69.0M, up from $51.9M.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets grew 14% to $304.4M (10-K FY 2025, Consolidated Balance Sheets). Current assets rose 25% to $151.3M, led by cash/marketable securities ($69.0M vs $51.9M) and a $17.2M increase in prepaid/other current assets (largely $15.3M insurance proceeds receivable). Inventory fell 45% to $9.3M. Leased equipment (net) grew 12% to $96.3M, supporting the subscription base. Current liabilities rose 27% to $123.0M, driven by a $16.4M increase in current deferred revenue to $74.9M and a $15.8M increase in accrued expenses (including the $15.0M legal accrual). Noncurrent deferred revenue fell to $16.7M from $20.3M. Long-term debt of $28.6M appeared (zero prior year). Contingent earn-out liability collapsed to $0.4M from $12.8M as milestones became improbable. Stockholders' equity was roughly flat at $119.4M vs $117.7M, with accumulated deficit widening to -$387.8M.

6. Data Gaps

• Quarterly financial statements (Condensed Consolidated Statements of Operations, Balance Sheets, Cash Flows) for Q2 2026, Q1 2026, Q3 2025, and Q2 2025 are not provided in the filings text; only the 10-K annual statements and a truncated MD&A excerpt for Q2 2026 are available.
• Quarterly revenue, gross profit, operating expenses, cash flow, and balance sheet figures for any quarter in 2025 or 2026 cannot be calculated or compared.
• Year-over-year quarterly trends (e.g., Q2 2026 vs. Q2 2025) cannot be assessed.
• The 10-Q filings for 2026-03-31, 2025-09-30, and 2025-06-30 are listed but their contents are not included in the provided documents.